C. Ola Landgren, Leader, Translational and Clinical Oncology Program/Experimental Therapeutics at Sylvester Comprehensive Cancer Center, shared on LinkedIn:
“Miami is moving the myeloma field fast forward, and last night’s Multiple Myeloma Research Foundation – MMRF Patient Summit captured that momentum!
More than 100 attendees joined in person, with another 300 participating remotely, for an inspiring evening with the Multiple Myeloma Research Foundation – MMRF in collaboration with the Sylvester Myeloma Institute at Sylvester Comprehensive Cancer Center, University of Miami.
Speakers and topics:
Benjamin Diamond – smoldering myeloma
Rafat Abonour – newly diagnosed multiple myeloma
C. Ola Landgren – future directions, new and emerging therapies
Gil Hevroni – relapsed/refractory multiple myeloma
David Coffey – supportive care
All faculty – Q&A
Exciting presentations and a lively Q&A brought patients, families, caregivers, and myeloma experts together to discuss advances in treatment, clinical trials, and the opportunities ahead.
The thoughtful questions reminded us why patient education and open dialogue are essential: progress means helping people understand their options and connecting scientific advances with better care.
Thank you to the Multiple Myeloma Research Foundation – MMRF, our Sylvester team, and everyone who joined us!
Together, we are accelerating discovery and working toward a future with more effective treatments and toward a cure, better quality of life, and lasting hope for people living with myeloma.”
Other articles about MMRF Patient Summit on OncoDaily.